Predicting outcomes for pregnant women with aplastic anemia
Part of Blood & lymphatic clinical trials.
This trial is testing a way to predict outcomes for pregnant women who have aplastic anemia, a condition where the bone marrow doesn't make enough blood cells. The goal is to help doctors and patients better manage the pregnancy and plan for the baby's delivery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be pregnant and have aplastic anemia, either diagnosed before or during this pregnancy.
- You must be 20 years or older.
- You must have had coagulation (clotting) blood tests done.
- You must not have ended a pregnancy before 20 weeks.
- You must be pregnant with only one baby (not twins or more).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how aplastic anemia affects reproductive and mental health in adults. By understanding these connections, doctors can provide better support for your overall well-being.
This study tests an experimental cell therapy called CK0801 for people with aplastic anemia who still need blood transfusions despite prior treatment. The goal is to see if it can help your bone marrow recover and reduce transfusion needs.
This study tests an AI-powered app called CURA to help identify pregnancies that may be at risk. It is designed for women in early pregnancy to see if the app can improve care.
This study looks at health data from pregnant women to find patterns that could help predict and catch health problems in mothers and babies early. It might offer better monitoring and care during and after pregnancy.
This study looks for factors that may predict how pregnancy turns out in people with lupus (SLE) and/or antiphospholipid syndrome (APS). It may help doctors better understand what to monitor in early pregnancy to support healthier outcomes.
This study looks at how well treatments work for children with acquired aplastic anemia, a condition where the bone marrow stops making enough blood cells. It aims to help doctors understand which treatments are most effective.
Hear when a new Aplastic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.